View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

About ZOMETA: defend against SREs across a broad range of tumour types

About ZOMETA
Breast Cancer
Dose ZOMETA every 3 to 4 weeks

Page

1 2 3 4

Real-world results confirm the benefits of dosing ZOMETA^® every 3 to 4 weeks¹⁶

Rate of SREs by dosing regimen^16*

*There are limitations to this study because the results are from a retrospective claims database analysis.

Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment¹⁶
No other dosing schedule is proven to protect patients from SREs^5,7,13,14

Using alternative dosing schedules significantly compromises the
benefits of ZOMETA¹⁶

Page

1 2 3 4

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Real-world results confirm the benefits of dosing ZOMETA® every 3 to 4 weeks16

Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment16

No other dosing schedule is proven to protect patients from SREs5,7,13,14

Using alternative dosing schedules significantly compromises thebenefits of ZOMETA16

Real-world results confirm the benefits of dosing ZOMETA^® every 3 to 4 weeks¹⁶

Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment¹⁶

No other dosing schedule is proven to protect patients from SREs^5,7,13,14

Using alternative dosing schedules significantly compromises the
benefits of ZOMETA¹⁶